Success of the peritoneal dialysis programme in Hong Kong.

A randomized controlled trial. J Am Coll Cardiol 2007; 50: 1015– 1020 7. Tepel M, Van Der Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180–184 8. Merten GJ, Burgess WP, Gray LV et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328–2334 9. Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrastagent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333–1340 10. Lameire NH. Contrast-induced nephropathy—prevention and risk reduction. Nephrol Dial Transplant 2006; 21: i11–i23 11. Solomon R, Deray G. Consensus panel for CIN. How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl 2006; 100: S51–S53 12. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006; 113: 1799– 1806 13. Thomsen HS. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur J Radiol 2006; 60: 307–313